Russia to enroll world’s first COVID-19 immunization on August 12 Kumar Jeetendra | August 10, 2020 The Russian COVID-19 vaccine candidate, being jointly developed by the Gamaleya Research Institute along with also the country’s Defence Ministry, is place to get registered on August 12, reports suggest. This would be the primary vaccine candidate against the novel coronavirus to become registered. News reports quoted Russia’s Deputy Health Minister Oleg Gridnev as confirming …
Germany says Russian COVID-19 immunization has not been adequately tried Kumar Jeetendra | August 12, 2020 German Health Minister Jens Spahn on Wednesday stated Russia’s COVID-19 vaccine had not been satisfactorily tested, including the goal would be to have a safe product instead of simply being first to start vaccinating people. President Vladimir Putin declared on Tuesday that Russia had become the first country to grant regulatory approval to a COVID-19 …
ICMR creating entrance for data on COVID-19 antibody Kumar Jeetendra | August 23, 2020 New Delhi, Aug 22 (PTI) The apex health research body, ICMR, is in the process of developing a vaccine portal which will offer information associated with the COVID-19 vaccine growth in India and abroad, with the majority of the upgrades in several regional languages along with English. The goal of producing the portal is to …
Stage 2 human preliminary of Oxford antibody may begin from August 26 in Pune Kumar Jeetendra | August 25, 2020 The trial may start from Wednesday, said a top official of the institute, among the 17 sites selected for the phase two human trials in the nation by Serum Institute of India (SII). “To begin with we’ve identified five volunteers who will undergo COVID-19 and antibodies test. Those whose reports are negative will be shortlisted …
Abbott’s card-sized 15-minute COVID-19 test gets USFDA gesture for emergency use Kumar Jeetendra | August 27, 2020 Abbott intends to send tens of millions of tests from September, ramping to 50 million tests a month at the beginning of October. BinaxNOW is the size of a credit card and gives results in 15 minutes. Abbott intends to market this evaluation for 5 (approx Rs 370), making it more reasonably priced than a …
India may get COVID-19 antibody by mid 2021: Bernstein Kumar Jeetendra | August 28, 2020 India is likely to acquire an approved COVID-19 vaccine by the first quarter of 2021, global brokerage firm Bernstein said in a report. “We’re optimistic that there will be an approved vaccine in the marketplace by 1Q calendar year 2021 in India,” the report stated. While the vaccine may be available at USD 3-6 (Rs …
Sanofi more certain about its coronavirus immunizations Kumar Jeetendra | August 29, 2020 Sanofi’s assurance in its own coronavirus vaccine candidates has increased this summer as the French drugmaker prepares to commence clinical trials, its chief executive told Reuters. The company is working on two of their more than 150 potential vaccines being developed throughout the world to tackle the COVID-19 pandemic, which has maintained over 831,000 lives …
WHO says India in converses with join ‘COVAX’ immunization plot Kumar Jeetendra | September 8, 2020 The World Health Organization is in discussions with India about linking the”COVAX” global vaccine allocation program, a senior WHO adviser said on September 7. “India is certainly eligible, like all countries in the world, to be a part of the COVAX centre and talks are continuing in that respect,” Bruce Aylward told a briefing in …
Russia finishes early preliminaries of second potential COVID-19 immunization: Report Kumar Jeetendra | September 8, 2020 Siberia’s Vector virology institute on September 8 finished early-stage human trials, called Phase II, of a second possible Russian vaccine against COVID-19, the state consumer safety watchdog was cited by the Interfax news agency as saying. Russia registered its first vaccine candidate, developed by Moscow’s Gamaleya Institute, in August after finishing early-stage human trials. “Today… …
Russia delivers first group of Sputnik V for open: Report Kumar Jeetendra | September 8, 2020 Russia has released the first batch of COVID-19 vaccine, called Sputnik V, into civil movement and the supplies of the medication to the Russian regions are expected soon, said a report citing Russian Health Ministry. The Russian health ministry enrolled the first vaccine against COVID-19, developed by Gamaleya National Research Center of Epidemiology and Microbiology …
Aurobindo Pharma ties up with BIRAC to create COVID-19 immunization Kumar Jeetendra | September 17, 2020 Aurobindo Pharma on Tuesday announced collaboration with the Biotechnology Industry Research Assistance Council (BIRAC), set up by the Department of Biotechnology for the development of COVID-19 vaccine. Aurobindo Pharma said it is developing a vaccine for COVID-19 through its wholly-owned US subsidiary, Auro Vaccines. “Aurobindo is in the process of preparing a state-of-art manufacturing facility …
Covid immunization: Bharat Biotech to utilize ViroVax’s adjuvant for Covaxin Kumar Jeetendra | October 5, 2020 Trials, will use adjuvant Alhydroxiquim-II to boost immune response and longer lasting immunity. The technology has been used under this licensing arrangement with US-based ViroVax. Adjuvant is used to boost the vaccine efficacy. Covaxin is an inactivated vaccine derived from a strain of SARS-CoV-2 virus, isolated in the National Institute of Virology (NIV), Pune under …
